ExSight Ventures
Venture capitalPre-Seed–Series B · 4 people tracked
Investment thesis
ExSight Ventures invests in early-stage companies developing breakthrough technologies to aid, diagnose, and treat people affected by vision diseases. The firm leverages deep ophthalmology domain expertise—led by two retinal surgeons—as an advantage over generalist investors, treating its focused specialization as a form of validation for a company's technology. It emphasizes capital efficiency, investing predominantly in technology development at the pre-seed through Series B stages. The firm argues that diversification is best achieved across focused managers rather than across holdings, and points to macro trends such as an aging population, rising diabetes, and a growing global middle class as drivers of demand for eye care innovation.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 6 of 23 portfolio companiesBiotech ×5Medical Devices ×2Healthtech ×1
HQs:United States×6
Investments · 23 tracked
founders shown can be your intro pathNovartis is a pharmaceutical company with a history spanning 250 years of scientific innovation.
BiotechSan Diego, US
Arthur T Suckow(Executive Officer)
Implant-free, minimally invasive glaucoma surgery (MIGS) creating microscopic channels in the eye to lower intraocular pressure.
Reinventing the eye exam with binocular OCT-based diagnostic technology.
Juvene Curvature Changing develops a fluid-optic intraocular lens designed to mimic the natural human lens and correct vision in patients with cataracts and presbyopia.
HealthtechMedical DevicesIrvine, US
Akiteru Furukawa(Director)Michael Colaco(Director)Ramgopal Rao(Executive Officer, Director)
British biotech startup with an AI-supported retinal biomarker for glaucoma and AMD clinical trials.
BiotechAnn Arbor, US
David Zacks(Executive Officer)David Esposito(Executive Officer, Director)Constance Chang(Executive Officer)Loic K Couraud(Director)William K Brinkerhoff(Director)Mark K Hooper(Director)
First-in-class optogenetic therapy for retinal diseases; acquired by Allergan.
BiotechAnn Arbor, US
Terry Cross(Director)Cam Gallagher(Director)Sean Ainsworth(Executive Officer, Director)George Lasezkay(Director)Kenneth Kousky(Director)
BiotechSan Diego, US
Ralph Bradshaw(Director)Christy Shaffer(Director)Schalon Newton(Executive Officer)David Eveleth(Executive Officer, Director)
Leveraging a multi-valent biopolymer to engineer medicines that overcome limitations of established drug targets.
Berkeley, US
Carole H Bellis(Executive Officer)Drew M Lanza(Director)Kevin E Healy(Director)Walter M Moos(Director)Jackson M Wesley(Executive Officer, Director)
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical Devices
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)Gregory D. Kunst(Chief Executive Officer)
Frequently asked questions
- What stage does ExSight Ventures invest at?
- ExSight Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does ExSight Ventures focus on?
- ExSight Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.